Randomized Controlled Multi-center Short Course Treatment for Rifampicin Resistant Tuberculosis
Condition: Tuberculosis Intervention: Drug: Total oral short-term therapy that includes linezolid, bedaquiline and/or cycloserine. Sponsor: Beijing Chest Hospital Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials